Skip to main content
OpenTrials
Completed

NCT Number: NCT01847508

PHILOS Augmented - a Multicenter Randomized Controlled Trial

The primary objective is to compare the mechanical failure risks in the first year after treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of Innsbruck, Innsbruck, Austria

Loading trial locations.

About this study

Biomechanical tests have shown that augmentation of screws or nails with polymethylmethacrylate (PMMA) leads to increased mechanical properties of the bone-implant complex, leading to the assumption that augmentation could reduce mechanical failures in patients. While a few clinical studies have already been performed with augmented trochanteric nails in proximal femur fractures, no clinical studies exist with the use of Proximal Humerus Internal Locking System (PHILOS) and (PMMA) augmentation for the treatment of fractures in the proximal humerus.

In this study a new standardized technique for augmentation of screw tips using high viscous PMMA cement (Traumacem V+) with the PHILOS plate will be applied. Fracture treatment with PHILOS Screw Augmentation will be compared with treatment with PHILOS without augmentation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years
  • Low energy trauma (e.g. fall from standing height)
  • Radiologically confirmed closed fracture (≤ 10 days) of the proximal humerus
  • Any displaced or unstable 3- or 4-part fracture of the proximal humerus (i.e. segment dis-placement > 0.5 cm or angulated > 45°) except isolated displaced fractures of the greater or lesser tuberosity
  • Primary fracture treatment with a PHILOS plate
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the clinical investigation including imaging and fol-low-up procedures
  • Signed informed consent

Preoperative Exclusion Criteria:

  • Bilateral or previous proximal humerus fractures on either side
  • Splitting fracture of the humeral head or humeral head impression fracture
  • Cuff-arthropathy of the contra- or ipsilateral proximal humerus
  • Associated nerve or vessel injury
  • Any known clotting disorders, severe cardiac and/or pulmonary insufficiency
  • Known hypersensitivity or allergy to any of the components of Traumacem V+ Cement Kit
  • Any severe systemic disease: class 4 - 6 of the American Society of Anesthesiologists (ASA) physical status classification
  • Any not medically managed severe systemic disease: class 3 of the ASA physical status classification
  • Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Intraoperative Exclusion Criteria:

  • Intraoperative decision to use implants other than PHILOS/PHILOS Screw Augmentation

Treatment and study plan

PHILOS+

Device

Proximal Humerus Internal Locking System with screw tip augmentation (PHILOS+) with high viscous polymethylmethacrylate (PMMA) cement (Traumacem V+).

Other names: PHILOS Length 90 mm with 3 shaft holes, PHILOS Length 114 mm with 5 shaft holes

Philos

Device

Proximal Humerus Internal Locking System (PHILOS).

Other names: PHILOS Length 90 mm with 3 shaft holes, PHILOS Length 114 mm with 5 shaft holes

Primary outcomes

  1. Any occurrence of radiographically confirmed mechanical failure during the first year after treatment.

    Time frame: one year

    Mechanical failures are defined as loss of reduction (≥ 15° increase of varus malposition between the immediate postoperative position and follow-up radiograph, relative change [5 mm] of greater or lesser tuberosity compared to the immediate postoperative position), head impaction (≥ 5 mm difference in outer plate edge and tangent of humeral head between immediate post-op and follow-up. The tangent is determined perpendicular to the humeral neck), screw/plate loosening (any change outwards of screw position in relation to immediate postoperative position) and secondary screw perforation (perforation of one or more screws through the humeral head into the joint space on the follow-up radiograph(and lack of screw perforation on the intra- or postoperative Rx based on a baseline anteroposterior and axial Rx.

Secondary outcomes

  1. Patient reported outcome (Quality of life)

    Time frame: Preoperative, 6 weeks ±7 days, 12 weeks ± 14 days, 6 months ± 30 days, 12 months up to 425 days after surgery

    EuroQol-5D (EQ-5D).

  2. Intra- and postoperative adverse events related to the procedure and/or device

    Time frame: Up to one year

    Implant/surgery , Bone/fracture, Soft tissue of the musculoskeletal system, Wound/other local tissue, Systemic/rest of the body.

  3. Reoperation rate

    Time frame: Up to one year

  4. Surgical details

    Time frame: Intraoperative

    Surgery duration (skin to skin in min).

  5. Description of augmentation details

    Time frame: Intraoperative

    Number of screws augmented.

  6. Surgical details

    Time frame: Intraoperative

    Time of day of surgery.

  7. Surgical details

    Time frame: Intraoperative

    Number and position of screws used.

  8. Surgical details

    Time frame: Intra- /postoperative

    Anatomic/non-anatomic reduction.

  9. Surgical details

    Time frame: Intra- /postoperative

    Restoration of medial support.

  10. Description of augmentation details

    Time frame: Intraoperative

    Number of incidences of direct contrast fluid leakage.

  11. Description of augmentation details

    Time frame: Intraoperative

    Augmentation-related adverse events and their association with fracture characteristics.

  12. Description of augmentation details

    Time frame: Intraoperative

    Volume of injected cement (in ml).

  13. Shoulder function

    Time frame: Preoperative, 6 weeks ±7 days, 12 weeks ± 14 days, 6 months ± 30 days, 12 months up to 425 days after surgery

    Shoulder Pain and Disability Index (SPADI).

  14. Shoulder function

    Time frame: Preoperative, 6 weeks ±7 days, 12 weeks ± 14 days, 6 months ± 30 days, 12 months up to 425 days after surgery

    Constant score.

  15. Shoulder function

    Time frame: Preoperative, 6 weeks ±7 days, 12 weeks ± 14 days, 6 months ± 30 days, 12 months up to 425 days after surgery

    Disabilities of the Arm, Shoulder and Hand Score (QuickDASH).

  16. Relation of patient factors on mechanical failures

    Time frame: Up to one year

    Comorbidity.

  17. Relation of patient factors on mechanical failures

    Time frame: Up to one year

    Mental health with Mini Mental State Examination (MMSE).

  18. Relation of patient factors on mechanical failures

    Time frame: Up to one year

    Bone mineral density (BMD) measured with CT.

  19. Relation of fracture characteristics on mechanical failures

    Time frame: Up to one year

    Number of fracture parts.

  20. Relation of fracture characteristics on mechanical failures

    Time frame: Up to one year

    Severity of displacement.

  21. Relation of fracture characteristics on mechanical failures

    Time frame: Up to one year

    Varus/valgus.

  22. Relation of surgical factors on mechanical failures

    Time frame: Up to one year

    Anatomic/non-anatomic reduction (varus, anteversion etc.).

  23. Relation of surgical factors on mechanical failures

    Time frame: Up to one year

    Restoration of medial support.

  24. Relation of surgical factors on mechanical failures

    Time frame: Up to one year

    Time of surgery.

Sponsors and collaborators

Lead sponsor

AO Clinical Investigation and Publishing Documentation

Other

Registry information

Official study title

A Multicenter Randomized Controlled Trial to Investigate the Treatment Outcome of PHILOS Screw Augmentation Compared to PHILOS Without Augmentation in Older Adult Patients With Proximal Humerus Fractures

Important dates

Study start
2013
Primary completion
2017
Study completion
2018
First posted
May 7, 2013
Registry last updated
Aug 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.